BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10874218)

  • 1. Suppression of tumor growth and downregulation of platelet-derived endothelial cell growth factor / thymidine phosphorylase in tumor cells by angiogenesis inhibitor TNP-470.
    Mori J; Haisa M; Naomoto Y; Takaoka M; Kimura M; Yamatsuji T; Notohara K; Tanaka N
    Jpn J Cancer Res; 2000 Jun; 91(6):643-50. PubMed ID: 10874218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of TNP-470-induced modifications to cell functions in HUVEC and cancer cells.
    Farinelle S; Malonne H; Chaboteaux C; Decaestecker C; Dedecker R; Gras T; Darro F; Fontaine J; Atassi G; Kiss R
    J Pharmacol Toxicol Methods; 2000; 43(1):15-24. PubMed ID: 11091126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of angiogenesis inhibitor TNP-470 on the growth, blood flow, and microvessel density in xenografts of human uterine carcinosarcoma in nude mice.
    Emoto M; Ishiguro M; Iwasaki H; Kikuchi M; Kawarabayashi T
    Gynecol Oncol; 2003 Apr; 89(1):88-94. PubMed ID: 12694659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of angiogenesis inhibitor TNP-470 on tamoxifen-stimulated MCF-7 breast tumors in nude mice.
    Takei H; Lee ES; Cisneros A; Jordan VC
    Cancer Lett; 2000 Jul; 155(2):129-35. PubMed ID: 10822127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and gemcitabine in a human bladder cancer KoTCC-1 model.
    Muramaki M; Miyake H; Hara I; Kawabata G; Kamidono S
    J Urol; 2004 Oct; 172(4 Pt 1):1485-9. PubMed ID: 15371876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Implication of vascular endothelial growth factor (VEGF) in human head and neck cancer].
    Ueno Y
    Nihon Jibiinkoka Gakkai Kaiho; 2006 Mar; 109(3):163-70. PubMed ID: 16615431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNP-470 promotes initial vascular sprouting in xenograft tumors.
    Huang J; Frischer JS; New T; Kim ES; Serur A; Lee A; Kadenhe-Chiwishe A; Pollyea DA; Yokoi A; Holash J; Yancopoulos GD; Kandel JJ; Yamashiro DJ
    Mol Cancer Ther; 2004 Mar; 3(3):335-43. PubMed ID: 15026554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis inhibitor TNP-470 reduces human pancreatic cancer growth.
    Hotz HG; Reber HA; Hotz B; Sanghavi PC; Yu T; Foitzik T; Buhr HJ; Hines OJ
    J Gastrointest Surg; 2001; 5(2):131-8. PubMed ID: 11331474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of the antiangiogenic agent TNP-470 on establishment and growth of hematogenous metastasis of human pancreatic carcinoma in SCID beige mice in vivo.
    Kawarada Y; Ishikura H; Kishimoto T; Saito K; Takahashi T; Kato H; Yoshiki T
    Pancreas; 1997 Oct; 15(3):251-7. PubMed ID: 9336788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of an anti-angiogenic agent, TNP-470, on the growth of oral squamous cell carcinomas.
    Ueda N; Kamata N; Hayashi E; Yokoyama K; Hoteiya T; Nagayama M
    Oral Oncol; 1999 Nov; 35(6):554-60. PubMed ID: 10705089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of the angiogenesis inhibitor TNP-470 on tumor growth and metastasis in nude mice bearing human hepatocellular carcinoma.
    Xia JL; Yang BH; Tang ZY; Sun FX; Xue Q; Gao DM
    J Cancer Res Clin Oncol; 1997; 123(7):383-7. PubMed ID: 9260590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of liver metastasis of human gastric carcinoma by angiogenesis inhibitor TNP-470.
    Shishido T; Yasoshima T; Denno R; Sato N; Hirata K
    Jpn J Cancer Res; 1996 Sep; 87(9):958-62. PubMed ID: 8878459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of TNP-470 on proliferation and apoptosis in human colon cancer xenografts in nude mice.
    Huang ZH; Fan YF; Xia H; Feng HM; Tang FX
    World J Gastroenterol; 2003 Feb; 9(2):281-3. PubMed ID: 12532448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of liver metastasis of human pancreatic carcinoma by angiogenesis inhibitor TNP-470 in combination with cisplatin.
    Shishido T; Yasoshima T; Denno R; Mukaiya M; Sato N; Hirata K
    Jpn J Cancer Res; 1998 Sep; 89(9):963-9. PubMed ID: 9818033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of angiogenesis to the progression of colon cancer: possible inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and hepatic metastasis.
    Takatsuka S; Yamada N; Sawada T; Ogawa Y; Maeda K; Ohira M; Ishikawa T; Nishino H; Seki S; Hirakawa-YS Chung K
    Int J Oncol; 2000 Aug; 17(2):253-8. PubMed ID: 10891532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladder.
    Inoue K; Chikazawa M; Fukata S; Yoshikawa C; Shuin T
    Clin Cancer Res; 2002 Jul; 8(7):2389-98. PubMed ID: 12114444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of pulmonary metastasis by angiogenesis inhibitor TNP-470 in murine osteosarcoma.
    Mori S; Ueda T; Kuratsu S; Hosono N; Izawa K; Uchida A
    Int J Cancer; 1995 Mar; 61(1):148-52. PubMed ID: 7535752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of tumor growth and metastasis by angiogenesis inhibitor TNP-470 on breast cancer cell lines in vitro and in vivo.
    Singh Y; Shikata N; Kiyozuka Y; Nambu H; Morimoto J; Kurebayashi J; Hioki K; Tsubura A
    Breast Cancer Res Treat; 1997 Aug; 45(1):15-27. PubMed ID: 9285113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth inhibition of liver metastases by the anti-angiogenic drug TNP-470.
    Gervaz P; Scholl B; Padrun V; Gillet M
    Liver; 2000 Apr; 20(2):108-13. PubMed ID: 10847478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of the angiogenesis inhibitor TNP-470 in reducing the growth of human neuroblastoma in nude mice inversely correlates with tumor burden.
    Katzenstein HM; Rademaker AW; Senger C; Salwen HR; Nguyen NN; Thorner PS; Litsas L; Cohn SL
    Clin Cancer Res; 1999 Dec; 5(12):4273-8. PubMed ID: 10632370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.